Emerging technology, new clinical algorithm target DKA
From the article
During multiple sessions at the 2026 Scientific Sessions, experts, including Viral N. Shah, MD, explored the potential, challenges, and questions surrounding continuous ketone monitoring and other considerations for diabetic ketoacidosis, which results in more than 250,000 hospital admissions in the U.S. each year. The post Emerging technology, new clinical algorithm target DKA appeared first on ADA Meeting News .
Continue reading on adameetingnews.orgYou might also wanna read
CKM Expert Panel Recommendations From the Adult Endocrinologist Perspective - YouTube
mdsc.pe·9d ago
Mayo Clinic Platform_Accelerate selects 20 healthcare technology startups for 30-week program
Mayo Clinic Platform_Accelerate has selected 20 healthcare technology startups for its 30-week accelerator program. The program provides sta
mayocl.in·14d agoSafety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection
clinicaltrials.gov·2d ago
ADA 2026 Scientific Sessions: New GLP-1 Drugs and Diabetes Research Highlights
In this JAMA Medical News podcast, Jennifer Abbasi interviews Dr. Rita Kalyani, the ADA's Chief Scientific and Medical Officer, about key hi
ja.ma·18d ago
Study Finds ChatGPT Gives Inconsistent Carb Estimates for Same Food Photos, Posing Risks for Diabetes Management
A study published as a preprint tested ChatGPT's reliability for carb counting by submitting 13 food photographs 500 times each. The AI gave
Diabettech - Diabetes and Technology | Where Diabetes and Technology meet·2mo ago
Personal Reflection on Using Proprietary Medical Devices for Diabetes Management
The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni
sfconservancy.org·6mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.